This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaux, D L Articles by Weissman, I L Search for Related Content PubMed PubMed Citation Articles by Vaux, D L Articles by Weissman, I L

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 November; 13(11): 7000-7005

Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2.

Department of Pathology, Stanford University Medical Center, California 94305.

ABSTRACT

Expression of c-myc and macromolecular synthesis have been associated with physiological cell death. We have studied their requirement for the death of factor (interleukin-3)-dependent cells (FDC-P1) bearing an inducible bcl-2 expression construct. FDC-P1 cells expressing bcl-2 turned off expression of c-myc when deprived of interleukin-3 but remained viable as long as bcl-2 was maintained. A subsequent decline in Bcl-2 allowed the cells to undergo apoptosis directly from G0, in the absence of detectable c-myc expression. Thus c-myc expression may lead to apoptosis in some cases but is not directly involved in the mechanism of physiological cell death that can be controlled by Bcl-2. The macromolecular synthesis inhibitors actinomycin D and cycloheximide triggered rapid cell death of FDC-P1 cells in the presence of interleukin-3, but the cells could be protected by Bcl-2. Thus, the cell death machinery can exist in a quiescent state and can be activated by mechanisms that do not require synthesis of RNA or protein.

This article has been cited by other articles:

• Kasof, G. M., Goyal, L., White, E. (1999). Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins. Mol. Cell. Biol. 19: 4390-4404 [Abstract] [Full Text]  
• Moffatt, S., Yaegashi, N., Tada, K., Tanaka, N., Sugamura, K. (1998). Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage Cells. J. Virol. 72: 3018-3028 [Abstract] [Full Text]  
• Polverino, A. J., Patterson, S. D. (1997). Selective Activation of Caspases During Apoptotic Induction in HL-60 Cells. EFFECTS OF A TETRAPEPTIDE INHIBITOR. J. Biol. Chem. 272: 7013-7021 [Abstract] [Full Text]  
• Shaham, S, Horvitz, H R (1996). Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities.. Genes Dev. 10: 578-591 [Abstract]  
• Rehen, S., Varella, M., Freitas, F., Moraes, M., Linden, R (1996). Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina. Development 122: 1439-1448 [Abstract]  
• Pérez-Sala, D., Collado-Escobar, D., Mollinedo, F. (1995). Intracellular Alkalinization Suppresses Lovastatin-induced Apoptosis in HL-60 Cells through the Inactivation of a pH-dependent Endonuclease. J. Biol. Chem. 270: 6235-6242 [Abstract] [Full Text]  
• Hamilton, E., Miller, K. M., Helm, K. M., Langdon, W. Y., Anderson, S. M. (2001). Suppression of Apoptosis Induced by Growth Factor Withdrawal by an Oncogenic Form of c-Cbl. J. Biol. Chem. 276: 9028-9037 [Abstract] [Full Text]